Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Womens Health ; 9: 315-321, 2017.
Article in English | MEDLINE | ID: mdl-28553144

ABSTRACT

The transdermal patch provides an effective and convenient option for hormonal contraception. The patch currently on the US market contains 150 µg norelgestromin and 35 µg ethinylestradiol (EE). The 20 cm2 patch is applied once weekly for 3 weeks, followed by a patch-free week, for a 21-7 cycle. Typical failure rates are similar to that of combined oral contraceptives (COCs). Transdermal delivery results in less peaks and troughs of estrogen, but a higher total estrogen exposure compared with COCs. Though studies show mixed results, the risk of developing venous thromboembolism (VTE) is about twice as high with the patch as with COCs; however, the absolute risk of VTE remains low. The side effect profile is similar to that of COCs, with slightly higher rates of breast tenderness plus a unique adverse effect of application site reactions. Two new patches have been developed, one containing gestodene and EE in Europe and another containing levonorgestrel and EE. Overall, the patch provides an alternative to COCs for women who want autonomy and the benefit of not needing to take a pill daily, with similar efficacy and tolerability.

2.
Dev Biol ; 369(2): 340-8, 2012 Sep 15.
Article in English | MEDLINE | ID: mdl-22819677

ABSTRACT

Fibroblast growth factor (FGF) signaling to the epithelium and mesenchyme mediated by FGF10 and FGF9, respectively, controls cecal formation during embryonic development. In particular, mesenchymal FGF10 signals to the epithelium via FGFR2b to induce epithelial cecal progenitor cell proliferation. Yet the precise upstream mechanisms controlling mesenchymal FGF10 signaling are unknown. Complete deletion of Fgf9 as well as of Pitx2, a gene encoding a homeobox transcription factor, both lead to cecal agenesis. Herein, we used mouse genetic approaches to determine the precise contribution of the epithelium and/or mesenchyme tissue compartments in this process. Using tissue compartment specific Fgf9 versus Pitx2 loss of function approaches in the gut epithelium and/or mesenchyme, we determined that FGF9 signals to the mesenchyme via Pitx2 to induce mesenchymal Fgf10 expression, which in turn leads to epithelial cecal bud formation.


Subject(s)
Cecum/embryology , Cecum/metabolism , Fibroblast Growth Factor 10/metabolism , Fibroblast Growth Factor 9/metabolism , Homeodomain Proteins/metabolism , Transcription Factors/metabolism , Animals , Base Sequence , Cecum/abnormalities , Cell Proliferation , DNA Primers/genetics , Epithelial Cells/cytology , Epithelial Cells/metabolism , Female , Fibroblast Growth Factor 10/deficiency , Fibroblast Growth Factor 10/genetics , Fibroblast Growth Factor 9/deficiency , Fibroblast Growth Factor 9/genetics , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Male , Mesoderm/embryology , Mesoderm/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Mice, Transgenic , Models, Biological , Pregnancy , Receptor, Fibroblast Growth Factor, Type 2/genetics , Receptor, Fibroblast Growth Factor, Type 2/metabolism , Signal Transduction , Transcription Factors/deficiency , Transcription Factors/genetics , Homeobox Protein PITX2
SELECTION OF CITATIONS
SEARCH DETAIL
...